Called the EuroAction Project, the study will analyse the lifestyles and health of as many as 20,000 patients, all of whom have a high risk of developing heart disease.
The society has hired Cohn & Wolfe to communicate the results of each stage of the study to Europe’s medical community.
The project also aims to promote the society’s guidelines on the treatment and prevention of heart disease.
Cohn & Wolfe healthcare MD Fiona McMillan said the absence in some European countries of specific targets for the reduction of cardiovascular disease meant that it was vital for doctors to adopt the society’s guidelines.
She added: ‘This study aims to show how effective implementing the society’s guidelines can be.’
In June the British Heart Foundation said that there were more than 878,000 heart failure patients in the UK, costing the NHS around £625m a year.